Comment: As athma incidence rises, tailor treatments better

With multiple types of asthma, better research and targeting of treatments are needed for equitable care.

By Matthew C. Altman / For The Herald

Every year, the number of people living with asthma continues to grow in the United States, with about 1 in 12 Americans affected according to the Centers for Disease Control and Prevention. Here in the Evergreen State, we lead as one of the nation’s highest for the prevalence of asthma.

With worsening air quality and pollution, including locally — last October, Seattle ranked first for worst air quality worldwide — people living with asthma are at risk for experiencing increasingly harmful effects. Multiple respiratory infections, including the common cold, RSV, influenza and covid-19, can also elevate the threat of one’s health when living with this lifelong disease. Our environment is signaling an alarm that we must do better for those living with asthma, and it starts with increasing education among clinicians, patients and communities.

Unfortunately, even in research and clinical practice, multiple types of asthma tend to get lumped together, preventing any focus on targeted therapies for specific types and different demographics. There are very different types of airway inflammation that may cause asthma in one person or another, and this can vary based on age, race or ethnicity, environmental exposures, and other factors. Historically, most clinical studies on asthma therapies are performed predominantly in white non-Hispanic adults, with fewer pediatric clinical studies and overall lack of inclusion of diverse populations. As a result, we often have relatively poorer understanding of their efficacy or safety for children and non-white populations, despite these being the populations most affected by asthma.

These pitfalls also make it very difficult to uncover preventive methods for different age groups, races and ethnicities. Even though asthma is considered the most common chronic disease in children, underappreciation of disease burden and under-treatment persist, especially in those with limited access to health care. Asthma-related hospital admissions may also reveal an increase in severity, poor disease management and/or the lack of access to appropriate treatment. And yet research is proving that vulnerable groups are being disproportionately affected and that new, targeted therapies are desperately needed.

In a recent paper that our research consortium, Childhood Asthma in Urban Settings (CAUSE), published, we found that elevated air quality index values are associated with asthma attacks, and lowered lung function in children living in low-income urban neighborhoods, and critically we identified molecular linkages between individual pollutants and asthma attacks. By understanding these mechanisms, we can now begin looking at targeted treatments that consider the impact of one’s environment and exposures. As far as treatments, we’ve found that a biologic asthma therapy called mepolizumab can reduce asthma attacks among children in low-income Hispanic and Black communities, an important finding, albeit the other critical finding in that study was that the therapy only works in certain children depending on their airway inflammatory subtype. This means it can be highly effective for some urban children with asthma but definitely not for others, and this can be identified in advance.

All this research makes the case for further studies and development of new, targeted therapies, particularly as we see air pollution consistently worsen, Americans become sicker with diseases that can trigger asthma, like obesity, and increasing cases of illness caused by respiratory infections.

As we continue to learn through research what works and what doesn’t, clinicians and communities can act now by staying educated on the latest asthma approaches to guide their understanding and treatment for patients. This is no longer just an issue of raising awareness but raising our capability to give our patients the best prevention strategies and treatments that we can.

Dr. Matthew C. Altman, doctor of medicine and master of philosophy, is a principal investigator at the Benaroya Research Institute, Center for Systems Immunology, and an associate professor at the University of Washington.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Opinion

toon
Editorial cartoons for Friday, Feb. 7

A sketchy look at the news of the day.… Continue reading

Curtains act as doors for a handful of classrooms at Glenwood Elementary on Monday, Sept. 9, 2024 in Lake Stevens, Washington. (Olivia Vanni / The Herald)
Editorial: Schools’ building needs point to election reform

Construction funding requests in Arlington and Lake Stevens show need for a change to bond elections.

Schwab: Trump proves not as bad as feared; it’s worse

Taking food and medicine from kids; surrendering control to Musk; is this what you voted for?

Keep necessary homeless service program at its Everett location

Regarding The Herald’s front-page coverage of the Hope ‘N Wellness community services… Continue reading

We can’t afford the rich not paying their fair share

In a recent column, Todd Welch claims that a wealth tax on… Continue reading

Can we find a politically moderate path, please?

I was just wondering what happened to the moderates. I am a… Continue reading

Kristof: World’s richest men take on world’s poorest people

Trump says the USAID is run by ‘radical lunitics.’ Is saving countless lives now lunacy.

FILE- In this Nov. 14, 2017, file photo Jaìme Ceja operates a forklift while loading boxes of Red Delicious apples on to a trailer during his shift in an orchard in Tieton, Wash. Cherry and apple growers in Washington state are worried their exports to China will be hurt by a trade war that escalated on Monday when that country raised import duties on a $3 billion list of products. (Shawn Gust/Yakima Herald-Republic via AP, File)
Editorial: Trade war would harm state’s consumers, jobs

Trump’s threat of tariffs to win non-trade concessions complicates talks, says a state trade advocate.

A press operator grabs a Herald newspaper to check over as the papers roll off the press in March 2022 in Everett. (Olivia Vanni / The Herald file photo)
Editorial: Push back news desert with journalism support

A bill in the state Senate would tax big tech to support a hiring fund for local news outlets.

Jayden Hill, 15, an incoming sophomore at Monroe High School is reflected in the screen of a cellphone on Wednesday, July 10, 2024 in Monroe, Washington. (Olivia Vanni / The Herald)
Editorial: Students need limits on cellphones in school

School districts needn’t wait for legislation to start work on policies to limit phones in class.

toon
Editorial cartoons for Thursday, Feb. 6

A sketchy look at the news of the day.… Continue reading

Lake Stevens school bond funds needed safety work at all schools

A parent’s greatest fear is for something bad to happen to their… Continue reading

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.